chr11:102660650:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr11:102,660,650-102,668,891 |
hg38 | chr11:102,789,919-102,798,160 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.024 | squamous cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
0.005 | Cardiomyopathy, Dilated | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Cardiovascular Diseases | NA | BeFree,GAD | Detail | |
0.002 | Carotid Artery Diseases | NA | GAD | Detail | |
0.005 | carotid stenosis | NA | BeFree,GAD | Detail | |
<0.001 | celiac disease | NA | BeFree | Detail | |
<0.001 | cerebellar ataxia | NA | BeFree | Detail | |
<0.001 | Transient ischemic attack | NA | BeFree | Detail | |
0.001 | Malignant tumor of cervix | Stroma cell induced transcription of matrix metalloprotease 1 (MMP1) and matrix ... | BeFree | 26006035 | Detail |
<0.001 | Chlamydia Infections | NA | BeFree | Detail | |
0.003 | Cholangitis, Sclerosing | NA | BeFree,GAD | Detail | |
0.005 | chondrosarcoma | NA | BeFree,LHGDN | Detail | |
0.003 | chordoma | NA | LHGDN | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
0.092 | ulcerative colitis | NA | BeFree,GAD,LHGDN,RGD | Detail | |
0.005 | colorectal carcinoma | NA | BeFree | Detail | |
0.147 | Colorectal Neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
0.005 | Connective Tissue Diseases | NA | GAD,LHGDN | Detail | |
<0.001 | Contracture | NA | BeFree | Detail | |
0.002 | coronary aneurysm | NA | GAD | Detail | |
0.006 | Coronary Arteriosclerosis | Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease s... | BeFree,GAD | 25372932 | Detail |
0.009 | Coronary heart disease | Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease s... | BeFree,GAD | 25372932 | Detail |
0.003 | Crohn Disease | NA | BeFree,LHGDN | Detail | |
<0.001 | cutis laxa | NA | BeFree | Detail | |
<0.001 | cystic fibrosis | NA | BeFree | Detail | |
<0.001 | Cyst | NA | BeFree | Detail | |
0.002 | Hearing Loss, Sudden | NA | GAD | Detail | |
0.003 | Cessation of life | NA | LHGDN | Detail | |
0.002 | Nasopharyngeal carcinoma | The results suggested that the Arg399Gln polymorphism of XRCC1 gene, the 1G/2G p... | BeFree | 25481674 | Detail |
<0.001 | dermatitis herpetiformis | NA | BeFree | Detail | |
<0.001 | Stasis dermatitis | NA | BeFree | Detail | |
<0.001 | dermatomyositis | NA | BeFree | Detail | |
0.001 | scleroderma | NA | BeFree | Detail | |
<0.001 | Diabetes | NA | BeFree | Detail | |
<0.001 | diabetes mellitus | NA | BeFree | Detail | |
0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
0.083 | Diabetes Mellitus, Non-Insulin-Dependent | Type 2 diabetes is associated with increased expression of APOE, BAX, MMP1, NFKB... | BeFree,GAD,RGD | 23337395 | Detail |
0.083 | Diabetes Mellitus, Non-Insulin-Dependent | When the analyses were adjusted for multiple risk factors, no interaction betwee... | BeFree,GAD,RGD | 24834994 | Detail |
0.002 | Diabetic Angiopathies | NA | GAD | Detail | |
<0.001 | diverticulitis | NA | BeFree | Detail | |
0.002 | eclampsia | NA | GAD | Detail | |
0.002 | Pathological accumulation of air in tissues | NA | GAD | Detail | |
0.012 | endometriosis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Enteritis | NA | BeFree | Detail | |
<0.001 | Eosinophilia | NA | BeFree | Detail | |
0.003 | epidermolysis bullosa | NA | BeFree,GAD | Detail | |
0.003 | Esophageal Neoplasms | NA | BeFree,GAD | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.005 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
<0.001 | Nonproliferative fibrocystic disease | NA | BeFree | Detail | |
<0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
0.002 | Fibrosis | NA | GAD | Detail | |
<0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
<0.001 | Gingival Diseases | NA | BeFree | Detail | |
<0.001 | glaucoma | NA | BeFree | Detail | |
0.001 | glioblastoma | NA | BeFree | Detail | |
0.001 | Glioma | NA | BeFree | Detail | |
0.120 | IgA glomerulonephritis | NA | CTD_human | Detail | |
0.002 | Graft Occlusion, Vascular | NA | GAD | Detail | |
<0.001 | Chronic Kidney Diseases | The Chi-square test, multivariable logistic regression analysis with adjustment ... | BeFree | 19578796 | Detail |
0.003 | Granuloma | NA | LHGDN | Detail | |
0.002 | Hay fever | NA | GAD | Detail | |
0.002 | Head and Neck Neoplasms | NA | GAD | Detail | |
0.081 | Heart failure | NA | BeFree,RGD | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
0.003 | hepatitis C | NA | BeFree,GAD | Detail | |
<0.001 | Hernia | NA | BeFree | Detail | |
0.003 | Diaphragmatic hernia | NA | LHGDN | Detail | |
<0.001 | Von Hippel-Lindau syndrome | NA | BeFree | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
<0.001 | Hypercholesterolemia, Familial | NA | BeFree | Detail | |
0.080 | Hyperplasia | NA | RGD | Detail | |
0.006 | Hypertensive disease | Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 level... | BeFree,GAD | 24913092 | Detail |
0.080 | pulmonary hypertension | NA | RGD | Detail | |
<0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
0.012 | Inflammation | NA | GAD,LHGDN | Detail | |
0.004 | Inflammatory Bowel Diseases | NA | BeFree,LHGDN | Detail | |
<0.001 | Keloid | NA | BeFree | Detail | |
<0.001 | actinic keratosis | NA | BeFree | Detail | |
0.003 | Kidney Failure, Chronic | NA | BeFree,GAD | Detail | |
0.002 | Kidney Neoplasm | NA | GAD | Detail | |
0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
<0.001 | Fibroid Tumor | NA | BeFree | Detail | |
0.083 | liver cirrhosis | NA | BeFree,GAD,RGD | Detail | |
0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
0.003 | Liver diseases | NA | LHGDN | Detail | |
0.005 | Liver neoplasms | NA | GAD | Detail | |
<0.001 | Low Back Pain | NA | BeFree | Detail | |
0.003 | Lung diseases | Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke in... | BeFree,LHGDN | 25497407 | Detail |
0.225 | Chronic Obstructive Airway Disease | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
0.136 | Lung Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.003 | Lyme disease | NA | LHGDN | Detail | |
0.004 | Lymphatic Metastasis | NA | BeFree,LHGDN | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
0.003 | Malaria, Cerebral | NA | LHGDN | Detail | |
0.007 | Malignant neoplasm of stomach | The contribution of the genetic variations of the matrix metalloproteinase-1 gen... | BeFree,GAD | 25148204 | Detail |
0.007 | Malignant neoplasm of stomach | Role of interstitial collagenase gene promoter polymorphism in the etiology of g... | BeFree,GAD | 25253367 | Detail |
0.018 | melanoma | NA | BeFree,LHGDN | Detail | |
<0.001 | meningioma | The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 g... | BeFree | 25269045 | Detail |
0.002 | mitral valve insufficiency | NA | GAD | Detail | |
0.002 | Mitral Valve Prolapse Syndrome | NA | GAD | Detail | |
0.005 | Mouth Neoplasms | NA | GAD | Detail | |
0.002 | Mucocutaneous Lymph Node Syndrome | NA | GAD | Detail | |
0.003 | multiple myeloma | NA | LHGDN | Detail | |
0.002 | multiple sclerosis | NA | GAD | Detail | |
<0.001 | muscular dystrophy | NA | BeFree | Detail | |
0.002 | Musculoskeletal Diseases | NA | GAD | Detail | |
0.103 | myocardial infarction | NA | BeFree,GAD,LHGDN,RGD | Detail | |
0.080 | Myocardial Reperfusion Injury | NA | RGD | Detail | |
0.006 | myopia | NA | BeFree,GAD | Detail | |
<0.001 | Nasal Polyps | NA | BeFree | Detail | |
0.002 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
<0.001 | Neck Neoplasms | NA | BeFree | Detail | |
0.125 | Neoplasm Invasiveness | NA | CTD_human,GAD,LHGDN | Detail | |
0.147 | Neoplasm Metastasis | Interestingly, experimental depletion of UEV1 in MDA-MB-231 cells reduces MMP1 e... | BeFree,CTD_human,LHGDN | 25022892 | Detail |
0.147 | Neoplasm Metastasis | A substantial proportion of the NME1-regulated genes identified in the analyses ... | BeFree,CTD_human,LHGDN | 25048347 | Detail |
0.147 | Neoplasm Metastasis | Growing evidences show that matrix metalloproteinase 1 (MMP1) plays important ro... | BeFree,CTD_human,LHGDN | 25391421 | Detail |
0.147 | Neoplasm Metastasis | In this study we evaluate the relationship between Pit-1 and two collagenases: m... | BeFree,CTD_human,LHGDN | 25527274 | Detail |
0.147 | Neoplasm Metastasis | Resistant cells expressed higher levels of genes coding for cancer stem cell mar... | BeFree,CTD_human,LHGDN | 25725450 | Detail |
0.147 | Neoplasm Metastasis | In conclusion, our data emphasizes the role of chemokines, especially CXCL10, in... | BeFree,CTD_human,LHGDN | 26079660 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.080 | nephrotic syndrome | NA | CTD_mouse | Detail | |
0.005 | Hepatitis C, Chronic | The aim of this work was to establish an association between the single-nucleoti... | BeFree | 23941979 | Detail |
0.002 | Fibrosis, Liver | The aim of this work was to establish an association between the single-nucleoti... | BeFree | 23941979 | Detail |
<0.001 | Melanocytic nevus | NA | BeFree | Detail | |
<0.001 | obesity | NA | BeFree | Detail | |
0.120 | ocular hypertension | NA | CTD_human | Detail | |
0.128 | oral submucous fibrosis | NA | BeFree,CTD_human,GAD | Detail | |
0.014 | Degenerative polyarthritis | Our results suggest that 2ccPA significantly reduces the pain response to OA by ... | BeFree,LHGDN | 25123228 | Detail |
0.014 | Degenerative polyarthritis | Using rabbit and human synovial fibroblast cell lines, we examined the effects o... | BeFree,LHGDN | 25496568 | Detail |
0.014 | Degenerative polyarthritis | To determine the effects of Bushenhuoxue formula (BHF) on interleukin-1 beta (IL... | BeFree,LHGDN | 25975052 | Detail |
<0.001 | osteomyelitis | NA | BeFree | Detail | |
<0.001 | osteoporosis | NA | BeFree | Detail | |
<0.001 | osteosarcoma | NA | BeFree | Detail | |
0.002 | ovarian carcinoma | NA | BeFree | Detail | |
<0.001 | Ovarian Cysts | NA | BeFree | Detail | |
<0.001 | Ovarian Diseases | NA | BeFree | Detail | |
<0.001 | Pain | Our results suggest that 2ccPA significantly reduces the pain response to OA by ... | BeFree | 25123228 | Detail |
<0.001 | papilloma | NA | BeFree | Detail | |
0.002 | Parkinson disease | NA | GAD | Detail | |
0.003 | Periodontal Diseases | NA | BeFree,GAD | Detail | |
0.002 | Periodontal Pocket | NA | GAD | Detail | |
0.015 | periodontitis | NA | BeFree,GAD | Detail | |
0.003 | Periodontitis, Juvenile | NA | BeFree,GAD | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
0.002 | pneumonia | NA | GAD | Detail | |
<0.001 | pneumothorax | NA | BeFree | Detail | |
0.003 | polycystic ovary syndrome | NA | BeFree,GAD | Detail | |
0.005 | pre-eclampsia | NA | GAD | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
0.002 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
0.008 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.003 | Pruritus | NA | BeFree,GAD | Detail | |
<0.001 | pterygium | NA | BeFree | Detail | |
0.004 | pulmonary emphysema | These findings establish that the two commonly proposed orthologs of MMP1, Mmp1a... | BeFree | 25497407 | Detail |
0.081 | pulmonary fibrosis | NA | BeFree,RGD | Detail | |
<0.001 | Respiration Disorders | NA | BeFree | Detail | |
<0.001 | Respiratory Tract Diseases | NA | BeFree | Detail | |
<0.001 | Rheumatoid Nodule | NA | BeFree | Detail | |
0.003 | localized scleroderma | NA | LHGDN | Detail | |
0.012 | systemic scleroderma | Both DHLA and NAC increased MMP-1 activity when SSc cells were stimulated with P... | BeFree,LHGDN | 25123250 | Detail |
0.080 | Scoliosis, unspecified | NA | RGD | Detail | |
<0.001 | Septicemia | NA | BeFree | Detail | |
0.003 | Dermatologic disorders | NA | BeFree,GAD | Detail | |
0.002 | Spinal Diseases | NA | GAD | Detail | |
0.003 | Stomach Neoplasms | NA | BeFree,LHGDN | Detail | |
0.002 | gastric ulcer | NA | GAD | Detail | |
<0.001 | Stricture of artery | NA | BeFree | Detail | |
0.003 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
0.003 | pigmented villonodular synovitis | NA | BeFree,LHGDN | Detail | |
0.002 | thrombosis | NA | GAD | Detail | |
0.002 | Tongue Neoplasms | NA | GAD | Detail | |
0.002 | tracheal stenosis | NA | GAD | Detail | |
0.002 | tuberculosis | In mice, transgenic expression of human matrix metalloproteinase 1 causes caseou... | BeFree | 25676469 | Detail |
0.008 | Tuberculosis, Pulmonary | NA | BeFree,GAD | Detail | |
<0.001 | Erythema | NA | BeFree | Detail | |
0.003 | Urinary Stress Incontinence | NA | BeFree,GAD | Detail | |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.003 | Varicosity | NA | BeFree,GAD | Detail | |
<0.001 | Vascular Diseases | NA | BeFree | Detail | |
<0.001 | xeroderma pigmentosum | NA | BeFree | Detail | |
<0.001 | epidermolysis bullosa acquisita | NA | BeFree | Detail | |
0.120 | epidermolysis bullosa dystrophica | NA | BeFree,CTD_human | Detail | |
0.121 | Hallopeau-Siemens Disease | An investigation into the MMP1 gene promoter region polymorphism--1607 2G with r... | BeFree,ORPHANET | 24899116 | Detail |
0.002 | Peripheral Vascular Diseases | NA | GAD | Detail | |
<0.001 | severe combined immunodeficiency | We also evaluated Pit-1 overexpression with MMP-1 and MMP-13 knockdown in a seve... | BeFree | 25527274 | Detail |
<0.001 | polymyositis | NA | BeFree | Detail | |
<0.001 | Alcohol abuse | NA | BeFree | Detail | |
<0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
0.002 | Left Ventricular Hypertrophy | NA | GAD | Detail | |
<0.001 | Amaurosis Fugax | NA | BeFree | Detail | |
<0.001 | Thyroid Gland Follicular Adenoma | NA | BeFree | Detail | |
0.007 | Premature Birth | NA | GAD | Detail | |
<0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Periosteal Disorder | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
0.010 | Malignant neoplasm of mouth | NA | BeFree,GAD | Detail | |
0.005 | Malignant neoplasm of brain | NA | GAD | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | NA | BeFree | Detail | |
<0.001 | Hemangioma of retina | NA | BeFree | Detail | |
<0.001 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | Old myocardial infarction | NA | BeFree | Detail | |
<0.001 | endometriosis of ovary | NA | BeFree | Detail | |
0.080 | Intervertebral Disc Degeneration | NA | BeFree,RGD | Detail | |
<0.001 | Mitochondrial Encephalomyopathies | NA | BeFree | Detail | |
<0.001 | MERRF syndrome | NA | BeFree | Detail | |
<0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
0.002 | Aortic Aneurysm, Abdominal | NA | GAD | Detail | |
0.004 | Tumor Progression | In bladder cancer xenograft models, R3Mab substantially blocked tumor progressio... | BeFree | 25326231 | Detail |
<0.001 | follicular adenoma | NA | BeFree | Detail | |
<0.001 | Anaplastic carcinoma | NA | BeFree | Detail | |
0.002 | Periodontal Attachment Loss | NA | GAD | Detail | |
0.002 | Lichen Planus, Oral | NA | GAD | Detail | |
<0.001 | Diabetic Foot | Calcitriol down-regulated MMP-1 and MMP-10 expression in DFU-derived keratinocyt... | BeFree | 25168880 | Detail |
<0.001 | exfoliation syndrome | NA | BeFree | Detail | |
<0.001 | Giant Cell Tumor of Bone | NA | BeFree | Detail | |
<0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Lobular | NA | BeFree | Detail | |
0.003 | cholangiocarcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | verrucous carcinoma | NA | BeFree | Detail | |
<0.001 | hemangioblastoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
<0.001 | Metastatic malignant neoplasm to brain | Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metast... | BeFree | 25691572 | Detail |
<0.001 | Reactive systemic amyloidosis | NA | BeFree | Detail | |
<0.001 | Adult type dermatomyositis | NA | BeFree | Detail | |
<0.001 | Trichiasis | NA | BeFree | Detail | |
0.003 | alpha 1-antitrypsin deficiency | NA | BeFree,GAD | Detail | |
0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Colitis, Collagenous | NA | BeFree | Detail | |
<0.001 | Inclusion Body Myositis (disorder) | NA | BeFree | Detail | |
<0.001 | Light chain disease | NA | BeFree | Detail | |
0.002 | Cancer of Nasopharynx | NA | GAD | Detail | |
0.002 | Fibrosis, Liver | NA | BeFree | Detail | |
<0.001 | Hepatitis, Autoimmune | NA | BeFree | Detail | |
0.027 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
<0.001 | Lyme Arthritis | NA | BeFree | Detail | |
<0.001 | age related macular degeneration | NA | BeFree | Detail | |
0.081 | Sepsis | NA | BeFree,RGD | Detail | |
0.023 | Chronic Periodontitis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Primary amyloidosis | NA | BeFree | Detail | |
<0.001 | Severe myopia | NA | BeFree | Detail | |
<0.001 | Coinfection | NA | BeFree | Detail | |
<0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
0.008 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell ... | BeFree | 25391977 | Detail |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
0.003 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | Prolapsed lumbar disc | In the present study, matrix metalloproteinase-1, -3, -8 and -9 (MMP-1, -3, -8 a... | BeFree | 25816023 | Detail |
0.001 | cervix carcinoma | Stroma cell induced transcription of matrix metalloprotease 1 (MMP1) and matrix ... | BeFree | 26006035 | Detail |
<0.001 | Restenosis | NA | BeFree | Detail | |
<0.001 | Superficial ulcer | NA | BeFree | Detail | |
<0.001 | Fibrous bands | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
<0.001 | Superior limbic keratoconjunctivitis | NA | BeFree | Detail | |
<0.001 | Glaucoma, Primary Open Angle | NA | BeFree | Detail | |
<0.001 | Collagenous Sprue | NA | BeFree | Detail | |
0.003 | Chronic liver disease | NA | BeFree,GAD | Detail | |
<0.001 | endometriosis of uterus | NA | BeFree | Detail | |
<0.001 | Multiple malignancy | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Cervical intraepithelial neoplasia grade 1 | NA | BeFree | Detail | |
0.080 | Fetal Hypoxia | NA | RGD | Detail | |
<0.001 | Isolated aortic stenosis | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of tongue | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of prostate | The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate... | BeFree,GAD | 25115393 | Detail |
<0.001 | Hereditary gingival fibromatosis | NA | BeFree | Detail | |
0.120 | Non-alcoholic Fatty Liver Disease | NA | CTD_human | Detail | |
0.083 | Osteoarthritis, Knee | NA | BeFree,GAD,RGD | Detail | |
<0.001 | Progressive pseudorheumatoid dysplasia | NA | BeFree | Detail | |
0.003 | endometrial carcinoma | A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix m... | BeFree,GAD | 24820961 | Detail |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Decreased drug resistance | NA | BeFree | Detail | |
0.003 | Metabolic syndrome X | NA | BeFree,GAD | Detail | |
0.005 | Hepatitis C, Chronic | NA | BeFree,GAD | Detail | |
<0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Ewings sarcoma | NA | BeFree | Detail | |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | primary sclerosing cholangitis | NA | BeFree | Detail | |
<0.001 | Carotid Atherosclerosis | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
0.002 | Carcinogenesis | Growing evidences show that matrix metalloproteinase 1 (MMP1) plays important ro... | BeFree | 25391421 | Detail |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.002 | prostate carcinoma | The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate... | BeFree | 25115393 | Detail |
0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
<0.001 | invasive cancer | NA | BeFree | Detail | |
0.010 | breast carcinoma | Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. | BeFree | 24972610 | Detail |
0.010 | breast carcinoma | Tyrosyl phosphorylated PAK1 also stimulates invasion of breast cancer cells in r... | BeFree | 25472536 | Detail |
0.010 | breast carcinoma | In this study we evaluate the relationship between Pit-1 and two collagenases: m... | BeFree | 25527274 | Detail |
0.010 | breast carcinoma | Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metast... | BeFree | 25691572 | Detail |
0.003 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.002 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.001 | colon carcinoma | NA | BeFree | Detail | |
0.005 | stomach carcinoma | The contribution of the genetic variations of the matrix metalloproteinase-1 gen... | BeFree | 25148204 | Detail |
0.005 | stomach carcinoma | Role of interstitial collagenase gene promoter polymorphism in the etiology of g... | BeFree | 25253367 | Detail |
<0.001 | airway disease | NA | BeFree | Detail | |
0.120 | Preterm premature rupture of membranes (disorder) | NA | CLINVAR | Detail | |
0.005 | Malignant neoplasm of kidney | NA | BeFree,GAD | Detail | |
0.002 | Scleroderma, Limited | NA | GAD | Detail | |
<0.001 | lymphangioleiomyomatosis | NA | BeFree | Detail | |
0.002 | Carotid Artery, Internal, Dissection | NA | GAD | Detail | |
<0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
0.002 | Pregnancy associated hypertension | NA | GAD | Detail | |
<0.001 | Arteriopathic disease | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Muscle fibrosis | NA | BeFree | Detail | |
<0.001 | Pelvic Organ Prolapse | NA | BeFree | Detail | |
<0.001 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
0.003 | Cardiomyopathies | NA | LHGDN | Detail | |
<0.001 | conjunctivochalasis | NA | BeFree | Detail | |
<0.001 | ovarian neoplasm | NA | BeFree | Detail | |
<0.001 | Ischemic stroke | Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms an... | BeFree | 24834994 | Detail |
0.005 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
0.080 | Arthritis, Experimental | NA | RGD | Detail | |
0.002 | HIV-Associated Lipodystrophy Syndrome | NA | GAD | Detail | |
0.008 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
0.002 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
0.002 | diffuse scleroderma | NA | GAD | Detail | |
0.002 | Stenosis | NA | GAD | Detail | |
0.004 | sarcoma | NA | BeFree,LHGDN | Detail | |
0.002 | Blood pressure finding | NA | GAD | Detail | |
0.002 | Systemic arterial pressure | NA | GAD | Detail | |
<0.001 | Epidermolysis bullosa pruriginosa | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | chronic venous insufficiency | NA | BeFree | Detail | |
<0.001 | Eosinophilic disorder | NA | BeFree | Detail | |
<0.001 | Peripheral arterial occlusive disease | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Hereditary Nonpolyposis Colorectal Cancer | NA | BeFree | Detail | |
<0.001 | Infiltrating Cervical Carcinoma | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Diabetic foot ulcer | Calcitriol down-regulated MMP-1 and MMP-10 expression in DFU-derived keratinocyt... | BeFree | 25168880 | Detail |
0.141 | Mammary Neoplasms | Finally, by immunohistochemistry we correlated Pit-1 with MMP-1 and MMP-13 prote... | BeFree,CTD_human,LHGDN | 25527274 | Detail |
<0.001 | Xenograft Model | We also evaluated Pit-1 overexpression with MMP-1 and MMP-13 knockdown in a seve... | BeFree | 25527274 | Detail |
0.027 | colorectal cancer | NA | BeFree,GAD | Detail | |
<0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Non-ST elevation (NSTEMI) myocardial infarction | NA | BeFree | Detail | |
0.081 | Tendinopathy | NA | BeFree,RGD | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | Disorder characterized by eosinophilia | NA | BeFree | Detail | |
<0.001 | Direct Contact Transmission Infection | NA | BeFree | Detail | |
<0.001 | Invasive Skin Melanoma | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Meningioma, benign, no ICD-O subtype | The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 g... | BeFree | 25269045 | Detail |
0.008 | Idiopathic Pulmonary Fibrosis | MMPs and their inhibitors, tissue inhibitors of MMPs (TIMPs), have been implicat... | BeFree,GAD,LHGDN | 26121236 | Detail |
<0.001 | uterine corpus cancer | A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix m... | BeFree | 24820961 | Detail |
<0.001 | Trichothiodystrophy Syndromes | TFIIH-dependent MMP-1 overexpression in trichothiodystrophy leads to extracellul... | BeFree | 25605938 | Detail |
0.003 | coronary artery disease | Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease s... | BeFree,GAD | 25372932 | Detail |
<0.001 | CAKUT | NA | BeFree | Detail | |
0.015 | liver carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.120 | Pulmonary disease, chronic obstructive, rate of decline of lung function in | NA | CLINVAR | Detail | |
<0.001 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | NA | BeFree | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
0.002 | Nasopharyngeal carcinoma | Matrix metalloproteinase-1 (MMP1) polymorphism is associated with lowered risk o... | BeFree | 25312481 | Detail |
0.002 | Nasopharyngeal carcinoma | The results suggested that the Arg399Gln polymorphism of XRCC1 gene, the 1G/2G p... | BeFree | 25481674 | Detail |
<0.001 | aggressive cancer | NA | BeFree | Detail | |
<0.001 | Nonalcoholic Steatohepatitis | NA | BeFree | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms an... | BeFree | 24834994 | Detail |
<0.001 | Early Hepatocellular Carcinoma | NA | BeFree | Detail | |
<0.001 | AA amyloidosis | NA | BeFree | Detail | |
<0.001 | Astrocytoma of brain | NA | BeFree | Detail | |
0.002 | Infection | NA | GAD | Detail | |
0.007 | adenocarcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | adenoma | NA | BeFree,LHGDN | Detail | |
0.005 | Airway Obstruction | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Alveolar Bone Loss | NA | GAD | Detail | |
0.005 | Alzheimer's disease | NA | BeFree,GAD | Detail | |
0.002 | amyotrophic lateral sclerosis | NA | GAD | Detail | |
0.121 | Aneurysm | NA | BeFree,CTD_human | Detail | |
0.005 | Anoxia | NA | GAD,LHGDN | Detail | |
<0.001 | aortic aneurysm | NA | BeFree | Detail | |
0.002 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Arteriovenous fistula | NA | BeFree | Detail | |
0.003 | arthritis | NA | BeFree,GAD | Detail | |
<0.001 | Arthritis, Psoriatic | NA | BeFree | Detail | |
0.026 | rheumatoid arthritis | NA | BeFree,GAD,LHGDN | Detail | |
0.008 | asthma | Extra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activit... | BeFree,GAD,LHGDN | 24587395 | Detail |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
0.132 | atherosclerosis | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
0.005 | Bladder Neoplasm | NA | LHGDN | Detail | |
0.003 | Bone Diseases | NA | BeFree,LHGDN | Detail | |
0.023 | Malignant neoplasm of breast | Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. | BeFree,GAD | 24972610 | Detail |
0.023 | Malignant neoplasm of breast | Tyrosyl phosphorylated PAK1 also stimulates invasion of breast cancer cells in r... | BeFree,GAD | 25472536 | Detail |
0.023 | Malignant neoplasm of breast | In this study we evaluate the relationship between Pit-1 and two collagenases: m... | BeFree,GAD | 25527274 | Detail |
0.023 | Malignant neoplasm of breast | Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metast... | BeFree,GAD | 25691572 | Detail |
0.002 | Bronchial Diseases | NA | GAD | Detail | |
0.003 | bronchiectasis | NA | BeFree,GAD | Detail | |
0.002 | bronchitis | NA | GAD | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of endometrium | A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix m... | BeFree | 24820961 | Detail |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
0.123 | Non-small cell lung carcinoma | NA | BeFree,CTD_human,GAD | Detail | |
0.012 | renal cell carcinoma | NA | BeFree,GAD,LHGDN | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stroma cell induced transcription of matrix metalloprotease 1 (MMP1) and matrix metalloprotease 2 (M... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease susceptibility: a cas... | DisGeNET | Detail |
Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease susceptibility: a cas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results suggested that the Arg399Gln polymorphism of XRCC1 gene, the 1G/2G polymorphism of MMP-1... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Type 2 diabetes is associated with increased expression of APOE, BAX, MMP1, NFKB1, PDGFB, SPP1, and ... | DisGeNET | Detail |
When the analyses were adjusted for multiple risk factors, no interaction between T2DM and MMP-1-160... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The Chi-square test, multivariable logistic regression analysis with adjustment for covariates, and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertens... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The contribution of the genetic variations of the matrix metalloproteinase-1 gene to the genetic sus... | DisGeNET | Detail |
Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, experimental depletion of UEV1 in MDA-MB-231 cells reduces MMP1 expression and preven... | DisGeNET | Detail |
A substantial proportion of the NME1-regulated genes identified in the analyses were of clear potent... | DisGeNET | Detail |
Growing evidences show that matrix metalloproteinase 1 (MMP1) plays important roles in tumorigenesis... | DisGeNET | Detail |
In this study we evaluate the relationship between Pit-1 and two collagenases: matrix metalloprotein... | DisGeNET | Detail |
Resistant cells expressed higher levels of genes coding for cancer stem cell markers (JARID1B, CD271... | DisGeNET | Detail |
In conclusion, our data emphasizes the role of chemokines, especially CXCL10, in BC progression and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this work was to establish an association between the single-nucleotide polymorphisms (SN... | DisGeNET | Detail |
The aim of this work was to establish an association between the single-nucleotide polymorphisms (SN... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results suggest that 2ccPA significantly reduces the pain response to OA by inducing hyaluronic ... | DisGeNET | Detail |
Using rabbit and human synovial fibroblast cell lines, we examined the effects of Cx43 overexpressio... | DisGeNET | Detail |
To determine the effects of Bushenhuoxue formula (BHF) on interleukin-1 beta (IL-1β), transforming g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results suggest that 2ccPA significantly reduces the pain response to OA by inducing hyaluronic ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These findings establish that the two commonly proposed orthologs of MMP1, Mmp1a and Mmp1b, provide ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Both DHLA and NAC increased MMP-1 activity when SSc cells were stimulated with PDGF. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In mice, transgenic expression of human matrix metalloproteinase 1 causes caseous necrosis, the path... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An investigation into the MMP1 gene promoter region polymorphism--1607 2G with recessive dystrophic ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We also evaluated Pit-1 overexpression with MMP-1 and MMP-13 knockdown in a severe combined immunode... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In bladder cancer xenograft models, R3Mab substantially blocked tumor progression and reduced the pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Calcitriol down-regulated MMP-1 and MMP-10 expression in DFU-derived keratinocytes but not in those ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cance... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present study, matrix metalloproteinase-1, -3, -8 and -9 (MMP-1, -3, -8 and -9) protein and m... | DisGeNET | Detail |
Stroma cell induced transcription of matrix metalloprotease 1 (MMP1) and matrix metalloprotease 2 (M... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (M... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Growing evidences show that matrix metalloproteinase 1 (MMP1) plays important roles in tumorigenesis... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. | DisGeNET | Detail |
Tyrosyl phosphorylated PAK1 also stimulates invasion of breast cancer cells in response to PRL and t... | DisGeNET | Detail |
In this study we evaluate the relationship between Pit-1 and two collagenases: matrix metalloprotein... | DisGeNET | Detail |
Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cance... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The contribution of the genetic variations of the matrix metalloproteinase-1 gene to the genetic sus... | DisGeNET | Detail |
Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Calcitriol down-regulated MMP-1 and MMP-10 expression in DFU-derived keratinocytes but not in those ... | DisGeNET | Detail |
Finally, by immunohistochemistry we correlated Pit-1 with MMP-1 and MMP-13 protein expression in 110... | DisGeNET | Detail |
We also evaluated Pit-1 overexpression with MMP-1 and MMP-13 knockdown in a severe combined immunode... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region ... | DisGeNET | Detail |
MMPs and their inhibitors, tissue inhibitors of MMPs (TIMPs), have been implicated in the pathogenes... | DisGeNET | Detail |
A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (M... | DisGeNET | Detail |
TFIIH-dependent MMP-1 overexpression in trichothiodystrophy leads to extracellular matrix alteration... | DisGeNET | Detail |
Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease susceptibility: a cas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase-1 (MMP1) polymorphism is associated with lowered risk of nasopharyngeal car... | DisGeNET | Detail |
The results suggested that the Arg399Gln polymorphism of XRCC1 gene, the 1G/2G polymorphism of MMP-1... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Extra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activity and increase airwa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. | DisGeNET | Detail |
Tyrosyl phosphorylated PAK1 also stimulates invasion of breast cancer cells in response to PRL and t... | DisGeNET | Detail |
In this study we evaluate the relationship between Pit-1 and two collagenases: matrix metalloprotein... | DisGeNET | Detail |
Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cance... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (M... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs17886084 dbSNP
- Genome
- hg19
- Position
- chr11:102,660,650-102,668,891
- Variant Type
- snv
Genome browser